Zurcher Kantonalbank (Zurich Cantonalbank)
BankPosition in LYEL — Lyell Immunopharma, Inc.
CIK 1368163
ZURICH, V8
Position in LYEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,715
+$3,749 QoQ
Shares Held
905
+102.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 87 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $587,075,858 across 175 Biotechnology names. LYEL ranks #158 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
380,762 | $189,135,908 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
431,148 | $103,893,733 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,644 | $39,684,579 | |
| 4 | INCY |
Incyte Corp
|
172,016 | $19,499,733 | |
| 5 | RPRX |
Royalty Pharma plc
|
312,891 | $17,543,798 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
74,284 | $13,911,907 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,536 | $13,707,702 | |
| 8 | MRNA |
Moderna, Inc.
|
162,175 | $11,357,115 |
All Filings in LYEL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,715 | 905 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $8,966 | 447 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $41,286 | 29,918 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,381 | 29,918 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $66,717 | 29,918 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $58,040 | 29,918 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $53,722 | 36,546 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $116,216 | 36,546 | Shares | Sole | 2023-08-07 | |
| No filing history on record for this holder in this stock. | ||||||